| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Departments of Pediatrics and Medicine, The Howard Hughes Medical Institute Laboratories, and the Metabolic Research Unit, University of California San Francisco, California 94143
Correspondence: Address all correspondence to Walter L. Miller, M.D., Department of Pediatrics, Room 677-S, University of California, San Francisco, San Francisco CA 94143. Supported by NIH grant HD16047 to WLM. Norman L. Eberhardt is a senior associate of the Howard Hughes Medical Institute.
Abstract
Introduction: GROWTH HORMONE (GH), prolactin (Prl), and chorionic somatomammotropin (CS, placental lactogen) are a family of polypeptide hormones that are related by function, immunochemistry, and structure (1–5). Despite their relatedness, these hormones are synthesized in a tissue-specific manner. GH and Prl are produced in the anterior pituitary, whereas CS is produced by the syncytiotrophoblast of the placenta. All three hormones possess lactogenic and growth-promoting activities. GH is required for postnatal growth and maintenance of nitrogen, mineral, lipid, and carbohydrate metabolism (6), while mammalian Prl is primarily involved in the initiation and maintenance of lactation (7). CS may provide GH-like activities to the developing fetus (8, 9), although it does not appear to be an essential hormone (10).
The three hormones have a similar size (190 to 199 amino acids among various species) and they all have similar protein structures. Each hormone has a single homologous tryptophan residue at about locus 85 (GH and CS) or 91 (Prl), and two homologous disulfide bonds.
This article has been cited by other articles:
![]() |
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis Physiol Rev, October 1, 2009; 89(4): 1177 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. DiGirolamo, A. Mukherjee, K. Fulzele, Y. Gan, X. Cao, S. J. Frank, and T. L. Clemens Mode of Growth Hormone Action in Osteoblasts J. Biol. Chem., October 26, 2007; 282(43): 31666 - 31674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Trujillo, M. Sakagashira, and N. L. Eberhardt The Human Growth Hormone Gene Contains a Silencer Embedded within an Alu Repeat in the 3'-Flanking Region Mol. Endocrinol., October 1, 2006; 20(10): 2559 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mukherjee, W. D. J. Ryder, A. Jostel, and S. M. Shalet Prolactin Deficiency Is Independently Associated with Reduced Insulin-Like Growth Factor I Status in Severely Growth Hormone-Deficient Adults J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2520 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Goffin, S. Bernichtein, P. Touraine, and P. A. Kelly Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists Endocr. Rev., May 1, 2005; 26(3): 400 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. D. Sharp and A. Bartke Evidence for Down-Regulation of Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR)-Dependent Translation Regulatory Signaling Pathways in Ames Dwarf Mice J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 293 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E Mullis Genetic control of growth Eur. J. Endocrinol., January 1, 2005; 152(1): 11 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. B. Cavaco, C. R.A. Santos, P. M. Ingleton, A. V.M. Canario, and D. M. Power Quantification of Prolactin (PRL) and PRL Receptor Messenger RNA in Gilthead Seabream (Sparus aurata) after Treatment with Estradiol-17{beta} Biol Reprod, February 1, 2003; 68(2): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Cho, H. Kimura, T. Minami, J. Ohgane, N. Hattori, S. Tanaka, and K. Shiota DNA Methylation Regulates Placental Lactogen I Gene Expression Endocrinology, August 1, 2001; 142(8): 3389 - 3396. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler The Somatomedin Hypothesis: 2001 Endocr. Rev., February 1, 2001; 22(1): 53 - 74. [Abstract] [Full Text] |
||||
![]() |
S. Khan, H. Katabuchi, M. Araki, R. Nishimura, and H. Okamura Human Villous Macrophage-Conditioned Media Enhance Human Trophoblast Growth and Differentiation In Vitro Biol Reprod, April 1, 2000; 62(4): 1075 - 1083. [Abstract] [Full Text] |
||||
![]() |
S. Kinet, S. Bernichtein, P. A. Kelly, J. A. Martial, and V. Goffin Biological Properties of Human Prolactin Analogs Depend Not Only on Global Hormone Affinity, but Also on the Relative Affinities of Both Receptor Binding Sites J. Biol. Chem., September 10, 1999; 274(37): 26033 - 26043. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dai, B. M. Chapman, B. Liu, K. E. Orwig, D. Wang, R. A. White, B. Preuett, and M. J. Soares A New Member of the Mouse Prolactin (PRL)-Like Protein-C Subfamily, PRL-Like Protein-C{alpha}: Structure and Expression Endocrinology, December 1, 1998; 139(12): 5157 - 5163. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text] |
||||
![]() |
F. de Zegher, B. Spitz, G. Van den Berghe, D. Lemmens, K. Vanweser, K. Keppens, and C. Y. Bowers Postpartum Hyperprolactinemia and Hyporesponsiveness of Growth Hormone (GH) to GH-Releasing Peptide J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 103 - 106. [Abstract] [Full Text] |
||||
![]() |
K. E. Orwig, R. Ishimura, H. Muller, B. Liu, and M. J. Soares Identification and Characterization of a Mouse Homolog for Decidual/Trophoblast Prolactin-Related Protein Endocrinology, December 1, 1997; 138(12): 5511 - 5517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Jiang, M. A. Trujillo, and N. L. Eberhardt Human Chorionic Somatomammotropin Enhancer Function Is Mediated by Cooperative Binding of TEF-1 and CSEF-1 to Multiple, Low-Affinity Binding Sites Mol. Endocrinol., August 1, 1997; 11(9): 1223 - 1232. [Abstract] [Full Text] |
||||
![]() |
S.-W. Jiang and N. L. Eberhardt The Human Chorionic Somatomammotropin Enhancers Form a Composite Silencer in Pituitary Cells in Vitro Mol. Endocrinol., August 1, 1997; 11(9): 1233 - 1244. [Abstract] [Full Text] |
||||
![]() |
F. M. Chuang, B. L. West, J. D. Baxter, and F. Schaufele Activities in Pit-1 Determine Whether Receptor Interacting Protein 140 Activates or Inhibits Pit-1/Nuclear Receptor Transcriptional Synergy Mol. Endocrinol., August 1, 1997; 11(9): 1332 - 1341. [Abstract] [Full Text] |
||||
![]() |
V. Goffin, S. Kinet, F. Ferrag, N. Binart, J. A. Martial, and P. A. Kelly Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay J. Biol. Chem., July 12, 1996; 271(28): 16573 - 16579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kinet, V. Goffin, V. Mainfroid, and J. A. Martial Characterization of Lactogen Receptor-binding Site 1of Human Prolactin J. Biol. Chem., June 14, 1996; 271(24): 14353 - 14360. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Jiang and N. L. Eberhardt Involvement of a Protein Distinct from Transcription Enhancer Factor-1 (TEF-1) in Mediating Human Chorionic Somatomammotropin Gene Enhancer Function through the GT-IIC Enhanson in Choriocarcinoma and COS Cells J. Biol. Chem., June 9, 1995; 270(23): 13906 - 13915. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Jiang, A. R. Shepard, and N. L. Eberhardt An Initiator Element Is Required for Maximal Human Chorionic Somatomammotropin Gene Promoter and Enhancer Function J. Biol. Chem., February 24, 1995; 270(8): 3683 - 3692. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Powers Fish as model systems Science, October 20, 1989; 246(4928): 352 - 358. [Abstract] [PDF] |
||||
![]() |
S. MELMED, G. D. BRAUNSTEIN, J. R. CHANG, and D. P. BECKER Pituitary Tumors Secreting Growth Hormone and Prolactin Ann Intern Med, August 1, 1986; 105(2): 238 - 253. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |